HSBC HOLDINGS PLC

Position in KURA — Kura Oncology, Inc.

CIK 873630 LONDON, X0

Position in KURA

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$723,830

+$183,519 QoQ

Shares Held

89,032

+71.2% QoQ

Ownership

0.100%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HSBC HOLDINGS PLC holds $961,918,485 across 122 Biotechnology names. KURA ranks #42 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	655,443	$292,681,510
2	REGN	Regeneron Pharmaceuticals, Inc.	323,338	$249,823,869
3	RPRX	Royalty Pharma plc	1,544,018	$74,066,541
4	INCY	Incyte Corp	582,368	$54,812,474
5	ALNY	Alnylam Pharmaceuticals, Inc.	89,619	$29,652,235
6	MRNA	Moderna, Inc.	490,088	$24,896,468
7	INSM	INSMED Inc	116,456	$19,042,883
8	PTCT	Ptc Therapeutics, Inc.	227,059	$15,469,528

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$723,830	89,032	+71.2%	Shares	Defined	2026-04-30
2025-12-31	$540,311	52,003	-60.4%	Shares	Defined	2026-03-20
2025-09-30	$1,161,049	131,192	-4.3%	Shares	Defined	2025-11-13
2025-06-30	$790,928	137,076	+151.6%	Shares	Defined	2025-08-13
2025-03-31	$359,640	54,491	+26.5%	Shares	Defined	2025-05-14
2024-12-31	$375,269	43,085	+166.6%	Shares	Sole	2025-02-14
2024-09-30	$315,824	16,163	-11.7%	Shares	Sole	2024-11-14
2024-06-30	$376,796	18,300	+13.4%	Shares	Defined	2024-08-12
2024-03-31	$344,116	16,133	-57.3%	Shares	Defined	2024-05-15
2023-12-31	$543,937	37,826	+13.8%	Shares	Defined	2024-02-12
2023-09-30	$303,120	33,237	+440.7%	Shares	Sole	2023-11-13
2020-12-31	$200,761	6,147	—	Shares	Defined	2021-02-25
No filing history on record for this holder in this stock.